On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV-1 IFA test kits. The original communication indicated that CTS inventory would be exhausted by September 1, 2019 but we now have sufficient inventory to last until September 30, 2019.
Check out the Communication page for the complete details by clicking the link: Communications
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...